Submission Details
| 510(k) Number | K170417 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | February 10, 2017 |
| Decision Date | September 15, 2017 |
| Days to Decision | 217 days |
| Submission Type | Traditional |
| Review Panel | Cardiovascular (CV) |
| Summary | Summary PDF |
K170417 is an FDA 510(k) clearance for the Glidewire GT, a Wire, Guide, Catheter (Class II — Special Controls, product code DQX), submitted by Terumo Corporation (Shibuya-Ku, JP). The FDA issued a Cleared decision on September 15, 2017, 217 days after receiving the submission on February 10, 2017. This device falls under the Cardiovascular review panel. Regulated under 21 CFR 870.1330.
| 510(k) Number | K170417 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | February 10, 2017 |
| Decision Date | September 15, 2017 |
| Days to Decision | 217 days |
| Submission Type | Traditional |
| Review Panel | Cardiovascular (CV) |
| Summary | Summary PDF |
| Product Code | DQX — Wire, Guide, Catheter |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 870.1330 |